Proteome Share News (PRM)

Proteome reaches milestone in launch of proteomics service

(Sharecast News) - Proteome Sciences has completed its next milestone towards the launch of 'single cell proteomics' services, it announced on Wednesday, dubbed 'SysQuant SCP'.

TRADING UPDATES: Proteome set for profit rise; Kromek expects loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Proteome Sciences maintains strong order book

(Sharecast News) - Proteome Sciences said in an update on Monday that it had maintained a strong order book after recording a small profit in 2021.

IN BRIEF: Proteome Sciences secures contract with US academic group

Proteome Sciences PLC - Drug development services provider - Secures a contract from major US academic group to evaluate changes on the proteome and phospho-proteome of tissue and blood samples taken from people with and without a neurodegenerative disease. The contract's value exceeds GBP500,000. Proteome refers to entire set of proteins in a cell or organism.

AIM WINNERS & LOSERS: Arc Minerals "turning point"; Titon posts loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:

TRADING UPDATES: Impellam and Maintel in profit; Curtis Banks prospers

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: Proteome Sciences amends GBP1 million loan with Vulpes

Proteome Sciences PLC - drug development services provider - Amends GBP1 million loan with Vulpes Investment Management Private Ltd, which was signed in the summer of 2018. Accrued interest now repayable on June 30, 2023, extended from May 1, 2022. Notes GBP700,000 is currently drawn on facility.

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

Proteome Sciences shares climb on GBP1 million contract win

Proteome Sciences shares climb on GBP1 million contract win

Proteome Sciences secures $1m contract with pharmaceutical major

(Sharecast News) - Proteomics and biomarker research firm Proteome Sciences has secured a contract valued at more than £1.0m from an unnamed major pharmaceutical company.

TRADING UPDATES: Headlam boosts outlook; Mothercare loss widens

TRADING UPDATES: Headlam boosts outlook; Mothercare loss widens

IN BRIEF: Proteome Sciences amends loan facility with Vulpes

IN BRIEF: Proteome Sciences amends loan facility with Vulpes